What is Onyx Biotec Ltd. Quarterly Revenue?

Onyx Biotec Ltd. Quarterly Revenue Onyx Biotec Mar-2026 Quarterly Revenue is Rs 0 Cr which is growth of 0% YoY.

What is Onyx Biotec Ltd. Quarterly Net Profit?

Onyx Biotec Ltd. Quarterly Net Profit Onyx Biotec Mar-2026 Quarterly Net Profit is Rs 0 Cr which is growth of 0% YoY.

What is Onyx Biotec Ltd. Annual Revenue?

Onyx Biotec Ltd. Annual Revenue Onyx Biotec Mar-2026 Annual Revenue is Rs 70 Cr which is growth of 10.8% YoY.

What is Onyx Biotec Ltd. Annual Net Profit?

Onyx Biotec Ltd. Annual Net Profit Onyx Biotec Mar-2026 Annual Net Profit is Rs -0 Cr which is growth of -104.3% YoY.

What is Onyx Biotec Ltd. Total Shareholders Fund?

Onyx Biotec Ltd. Total Shareholders Fund Onyx Biotec Mar-2026 Total Shareholders Fund is Rs 55 Cr which is growth of -0.4% YoY.

What is Onyx Biotec Ltd. Total Assets?

Onyx Biotec Ltd. Total Assets Onyx Biotec Mar-2026 Total Assets is Rs 95 Cr which is growth of 4.3% YoY.

What is Onyx Biotec Ltd. Book Value Per Share?

Onyx Biotec Ltd. Book Value Per Share Onyx Biotec Mar-2026 Book Value Per Share is 31 Rs which is growth of -0.4% YoY.

What is Onyx Biotec Ltd. ROE?

Onyx Biotec Ltd. ROE Onyx Biotec Mar-2026 ROE is -0% which is growth of 9.3% YoY.

What is Onyx Biotec Ltd. Cash From Operating Activity?

Onyx Biotec Ltd. Cash From Operating Activity Onyx Biotec Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -205.4% YoY.

What is Onyx Biotec Ltd. Net Cash Flow?

Onyx Biotec Ltd. Net Cash Flow Onyx Biotec Mar-2026 Net Cash Flow is Rs -5 Cr which is growth of -164.0% YoY.

ONYX quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

ONYX competitor comparison and performance snapshot within industry

ONYX annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Onyx Biotec Mar-2026 Annual Revenue is Rs 70 Cr which is growth of 10.8% YoY.
NEGATIVE
Annual Net Profit Onyx Biotec Mar-2026 Annual Net Profit is Rs -0 Cr which is growth of -104.3% YoY.

Onyx Biotec Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	20.9%	69.9	63.1	53.9	39.6	45
TotalOperatingRevenues_A Operating Rev. Ann.	20.7%	69.5	62	53.8	39.5	44.9
OI_A Other Income Ann.	58.7%	0.4	1.2	0.1	0.1	0.1
OEXPNS_A Operating Exp. Ann.	23.6%	66.1	51.6	45.5	35	39.2
OEXPNS_A Operating Exp. Ann.	23.6%	66.1	51.6	45.5	35	39.2
OP_A Operating Profit Ann.	-8.9%	3.4	10.3	8.3	4.5	5.6
OPMPCT_A OPM Ann. %	-24.4%	4.86%	16.39%	15.37%	11.25%	12.53%
TotalExpenses_A Total Exp. Ann. ⌄	23.7%	70.3	56.6	49.8	37.1	41.2
OtherExpenses_A Other Exp. Ann.	18.3%	5.8	3.8	3.7	3.5	4.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	-6.4%	8.6	8.6	6	10.5	8.6
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	-6.2%	3.8	11.5	8.4	4.6	5.8
EBIDTPCT_A EBITDA Ann. margin %	-22%	5.49%	18.24%	15.61%	11.59%	12.80%
INT_A Interest Ann.	26%	1.2	2	2.1	0.6	0.5
DEP_A Depr.	27.4%	3.1	3.1	2.3	1.5	1.5
PBT_A PBT Ann.	-	-0.4	6.5	4.1	2.6	3.8
TAX_A Tax Ann.	-	-0.2	1.5	1	0.7	0.4
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	-	-0.2	5	3	1.8	3.4
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-
NP_A Net Profit Ann.	-	-0.2	5	3	1.8	3.4
NETPCT_A NPM Ann. %	-	-0.30%	7.99%	5.64%	4.67%	7.47%
EPS_adj_A EPS Adj. latest Ann.	-	-0.1	2.7	1.7	1	1.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

10.8%

2Y CAGR

13.9%

3Y CAGR

20.9%

Operating Exp. Ann.

1Y CHG

28.1%

2Y CAGR

20.5%

3Y CAGR

23.6%

ONYX balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Total Shareholders Fund Onyx Biotec Mar-2026 Total Shareholders Fund is Rs 55 Cr which is growth of -0.4% YoY.
POSITIVE
Total Assets Onyx Biotec Mar-2026 Total Assets is Rs 95 Cr which is growth of 4.3% YoY.

Onyx Biotec Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	44.9%	55.4	55.6	24.9	18.2	16.4
EQCAP_A Equity Share Capital Ann.	45.3%	18.1	18.1	13.3	5.9	5.9
TotalShareCapital_A Total Share Capital Ann.	45.3%	18.1	18.1	13.3	5.9	5.9
ReservesAndSurplus_A Reserves Plus Surplus Ann.	44.7%	37.3	37.5	11.6	12.3	10.5
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	44.7%	37.3	37.5	11.6	12.3	10.5
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-29.2%	7.2	9.9	26.7	20.3	10.4
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	9.6%	2.5	3.1	2.6	1.9	1.4
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-
CL_A Total Current Liabilities Ann. ⌄	17.2%	32.5	25.7	22.6	20.2	10
TradePayables_A Trade Payables Ann.	36.9%	17.7	16.7	13.8	6.9	4.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	13.2%	2.9	2.3	1.3	2	2.1
ShortTermProvisions_A ST Provisions Ann.	146.6%	1.5	1	0.3	0.1	0.1
TL_A Total Capital Plus Liabilities Ann.	17.5%	95.2	91.3	74.1	58.7	36.8
FixedAssets_A Fixed Assets Ann. ⌄	-1.1%	42.8	40.9	44.6	44.2	22.4
TangibleAssets_A Tangible Assets Ann.	-2.7%	39.2	40.9	43.5	42.5	17.2
IntangibleAssets_A Intangible Assets Ann.	-			1.1	1.7	1.2
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	3.7				4
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-0.2%	43.9	42.1	44.6	44.2	22.4
NonCurrentInvestments_A Non Current Investments Ann.	-
DeferredTaxAssets_A Deferred Tax Assets Ann.	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	1	1.2
CA_A Total Current Assets Ann. ⌄	52%	51.3	49.2	29.6	14.6	14.4
CurrentInvestments_A Current Investments Ann.	-
TradeReceivables_A Trade Receivables Ann.	75.4%	27.5	20.2	15.4	5.1	8.4
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-	4	8.6	1.5	0	0
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	38.7%	0.8	0.2	0.3	0.3	2.6
OtherCurrentAssets_A Other Current Assets Ann.	19.1%	4.9	4.1	3.3	2.9	0.3
TA_A Total Assets Ann.	17.5%	95.2	91.3	74.1	58.7	36.8
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	5.9	5.9	5.9
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

4.3%

2Y CAGR

13.3%

3Y CAGR

17.5%

Total Current Liabilities Ann.

1Y CHG

26.5%

2Y CAGR

19.9%

3Y CAGR

17.2%

Total ShareHolders Funds Ann.

1Y CHG

-0.4%

2Y CAGR

49.2%

3Y CAGR

44.9%

ONYX ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Onyx Biotec Mar-2026 Book Value Per Share is 31 Rs which is growth of -0.4% YoY.
POSITIVE
ROE Onyx Biotec Mar-2026 ROE is -0% which is growth of 9.3% YoY.

Onyx Biotec Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
BVSH_A BVSH Ann.	-0.2%	30.6	30.7	18.7	30.8	27.8
ROA_A RoA Ann. %	-	-0.22%	5.42%	4.08%	3.14%	9.10%
ROE_A ROE Ann. %	-	-0.38%	8.90%	12.18%	10.13%	20.47%
ROCE_A ROCE Ann. %	-46.1%	1.26%	12.91%	11.95%	8.05%	16.07%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-21.9%	5.53%	18.58%	15.64%	11.63%	12.83%
PBITMargin_A EBIT Ann. Margin %	-47.6%	1.13%	13.66%	11.45%	7.85%	9.60%
PBTMargin_A PBT Ann. Margin %	-	-0.60%	10.45%	7.53%	6.45%	8.46%
NETPCT_A NPM Ann. %	-	-0.30%	7.99%	5.64%	4.67%	7.47%
ASETTO_A Asset Turnover Ann. %	0%	0.8	0.8	0.8	0.8	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	31.7%	1.6	1.9	1.3	0.7	1.4
QuickRatio_A Quick Ratio Ann.	40.1%	1.1	1.3	0.9	0.4	1.1
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-	72.8	109
EVPerNetSales_A EV Per Net Sales Ann.	-	1.1	1.8	-	-	-
PBV_A Price To Book Value Adjusted	0.6%	1.15	1.16	2.14	1.13	1.26
EVPerEBITDA_A EV Per EBITDA Ann.	-	19	9.5	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	0.9	1.7	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-
EYield_A Earnings Yield Ann.	-		0.1
DEBT_CE_A Total Debt to Total Equity Ann.	-42.8%	0.3	0.2	1.2	1.6	0.8

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Current Ratio Ann.

1Y CHG

-15.8%

2Y CAGR

10.9%

3Y CAGR

31.7%

ONYX cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Onyx Biotec Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -205.4% YoY.
NEGATIVE
Net Cash Flow Onyx Biotec Mar-2026 Net Cash Flow is Rs -5 Cr which is growth of -164.0% YoY.

Onyx Biotec Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
CFO_A Cash from Operating Act. Ann. ⌄	-	-1.5	1.4	1.5	2	0.5
PBT_A PBT Ann.	-	-0.4	6.5	4.1	2.6	3.8
INT_A Interest Ann.	26%	1.2	2	2.1	0.6	0.5
TAX_A Tax Ann.	-	-0.2	1.5	1	0.7	0.4
CFI_A Cash from Investing Act. Ann.	-	-4.6	0.7	-3.2	-22.7	-5.8
CFA_A Cash from Financing Act. Ann.	-54.9%	1.5	5.1	3.1	16.4	5.2
NCF_A Net Cash Flow Ann. ⌄	-	-4.6	7.2	1.5	-4.3	-0.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-	8.6	1.5	0	0	0.1
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-	4	8.6	1.5	-4.3	0

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

1Y CHG

-70.6%

2Y CAGR

-30.4%

3Y CAGR

-54.9%

ONYX investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

ONYX quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

ONYX - Competitors/Peers

ONYX competitor comparison and performance snapshot within industry

ONYX - Annual

ONYX annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Onyx Biotec Mar-2026 Annual Revenue is Rs 70 Cr which is growth of 10.8% YoY.

Annual Net Profit Onyx Biotec Mar-2026 Annual Net Profit is Rs -0 Cr which is growth of -104.3% YoY.

ONYX - Balance Sheet

ONYX balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Onyx Biotec Mar-2026 Total Shareholders Fund is Rs 55 Cr which is growth of -0.4% YoY.

Total Assets Onyx Biotec Mar-2026 Total Assets is Rs 95 Cr which is growth of 4.3% YoY.

ONYX - Ratios

ONYX ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Book Value Per Share Onyx Biotec Mar-2026 Book Value Per Share is 31 Rs which is growth of -0.4% YoY.

ROE Onyx Biotec Mar-2026 ROE is -0% which is growth of 9.3% YoY.

ONYX - Cash Flow

ONYX cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Cash From Operating Activity Onyx Biotec Mar-2026 Cash From Operating Activity is Rs -1 Cr which is growth of -205.4% YoY.

Net Cash Flow Onyx Biotec Mar-2026 Net Cash Flow is Rs -5 Cr which is growth of -164.0% YoY.

ONYX - Documents

ONYX investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access